Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Sep;77(1):116-22.

A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes

Affiliations

A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes

N Fernandez et al. Immunology. 1992 Sep.

Abstract

Human histocompatibility leucocyte antigen (HLA)-specific monoclonal antibody probes were used to determine the affinity constant, and cell-surface density of HLA class I and class II determinants. The measurements were estimated for single-cell units of B-lymphoblastoid cell line (B-LCL) and cloned activated T cells in different functional states. Each HLA subset showed unimodal affinity constant values for the interaction with the corresponding HLA-specific antibodies. Such values ranged between 2.2 x 10(7) M-1 (class I) and 4.0 x 10(7) M-1 (class II) for different histocompatibility epitopes. In both B and T cells there was a rank order of epitope expression, class I being highly expressed (5 x 10(6) epitopes/cell) followed by DR, DQ and DP, (1.1-3.0 x 10(6) epitopes/cell). Suppressive clones carrying functionally defined stimulating determinants previously designated 'DY' carried similar numbers of DR, DQ and DP binding sites to DY- non-suppressive clones, but showed selective increases of class II determinants reactive with broad class II-specific antibodies. The results are discussed in the context of the functional consequences of different patterns of HLA epitope expression in immune responses.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1989 Aug 1;143(3):902-6 - PubMed
    1. Nature. 1983 Jul 28-Aug 3;304(5924):358-61 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4887-9 - PubMed
    1. Ann Inst Pasteur Immunol. 1985 Jan-Feb;136C(1):103-19 - PubMed
    1. Biochem J. 1973 Jul;133(3):529-39 - PubMed

Publication types

LinkOut - more resources